Sarepta Therapeutics Inc (LTS:0L35)
$ 121.67 0 (0%) Market Cap: 11.61 Bil Enterprise Value: 11.80 Bil PE Ratio: 78.90 PB Ratio: 9.50 GF Score: 82/100

Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 03, 2021 / 01:00PM GMT
Release Date Price: $74.79 (-3.32%)
Operator

Hello, and welcome to the Annual Meeting of Stockholders of Sarepta Therapeutics Inc. Please note that today's meeting is being recorded.

(Operator Instructions)

It is now my pleasure to turn today's meeting over to Dr. M. Kathleen Behrens. Dr. Behrens, the floor is yours.

M. Kathleen Behrens
Sarepta Therapeutics, Inc. - Independent Chairwoman

Thank you, Chris. Welcome to the 2021 Annual Meeting of Stockholders for Sarepta Therapeutics. It is now 9:00 a.m., and the meeting will please come to order. My name is Dr. M. Kathleen Behrens, and as chairwoman of the Board of Directors of Sarepta, I will be presiding over this meeting. Doug Ingram, President and Chief Executive Officer of Sarepta, will also preside over portions of the meeting. Ryan Brown Senior Vice President, General Counsel and Corporate Secretary, will record the proceedings.

We would now like to take a moment to acknowledge the contributions of Dr. John C. Martin, former Sarepta Board member and renowned biotech leader, who passed away unexpectedly on March 30 of this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot